Wanbury Limited — Updates, 29-01-2025: Press Release
Wanbury Limited has appointed Mr. Rashesh Patel as Corporate Director for the India Formulation Business. With over four decades of experience in the pharmaceutical industry, Mr. Patel joins from Kepler Healthcare, where he played a key role in securing awards for best product launches and marketing excellence. His impressive track record includes transforming Corona Remedies from a partially operational company to a six-division entity, significantly improving its market ranking. Additionally, he has built business units and developed high-performing teams in various companies, including Troikaa Pharmaceuticals. Wanbury expects that Mr. Patel's leadership will propel the India Formulation Business towards enhanced growth and market leadership.
